The Sai Parenterals IPO 2026 is gaining attention among investors looking for opportunities in the pharmaceutical sector. In this blog, we cover everything you need to know, including Sai Parenterals IPO GMP today, price band, subscription details, allotment status, listing date, and a detailed review to help you decide whether to apply.
📊 Sai Parenterals IPO Details
The Sai Parenterals IPO is a book-building issue worth ₹408.79 crores, consisting of a mix of fresh issue and offer for sale (OFS).
- IPO Open Date: March 24, 2026
- IPO Close Date: March 27, 2026
- Allotment Date: March 30, 2026
- Listing Date: April 2, 2026
- Listing On: BSE & NSE
💰 Issue Breakdown:
- Fresh Issue: ₹285.00 crores (0.73 crore shares)
- Offer for Sale: ₹123.79 crores (0.32 crore shares)
- Total Shares Offered: 1,04,28,288 shares
💵 Sai Parenterals IPO Price Band & Lot Size
The Sai Parenterals IPO price band is set between:
- ₹372 to ₹392 per share
- Face Value: ₹5 per share
- Lot Size: 38 shares
🧾 Investment Details:
- Retail Minimum Investment: ₹14,896 (approx.)
- sNII Investment: ₹2,08,544 (14 lots)
- bNII Investment: ₹10,12,928 (68 lots)
📈 Sai Parenterals IPO GMP Today
As per the latest update, the Sai Parenterals IPO GMP today is:
- GMP: ₹0 (as of March 19, 2026)
- Estimated Listing Price: ₹392
- Expected Gain/Loss: 0%
The grey market trend shows no significant movement, indicating a neutral sentiment among investors. Based on recent GMP trends, the listing may remain close to the issue price unless market conditions change.
📊 Sai Parenterals IPO Subscription Status
The Sai Parenterals IPO subscription status will be updated during the bidding period (March 24–27, 2026). Typically, strong subscription numbers—especially in QIB and retail categories—indicate higher investor interest.
👉 Stay updated daily to track real-time subscription data.
🧾 Sai Parenterals IPO Allotment Status
The Sai Parenterals IPO allotment status is expected to be finalized on:
- March 30, 2026
Investors can check their allotment status via:
- Registrar’s website
- BSE/NSE official portals
Shares will be credited to Demat accounts on April 1, 2026, and refunds (if any) will also be processed on the same day.
📅 Sai Parenterals IPO Listing Date
The Sai Parenterals IPO listing date is scheduled for:
- April 2, 2026 (Thursday)
The stock will be listed on both BSE and NSE, and its performance will depend on market sentiment and subscription demand.
🧠 Sai Parenterals IPO Review
✅ Positives:
- Operates in the pharmaceutical sector, which has long-term growth potential
- Balanced issue structure (fresh issue + OFS)
- Reasonable pricing compared to industry peers
⚠️ Concerns:
- GMP is flat (₹0) indicating cautious sentiment
- No strong grey market premium to suggest listing gains
- Market conditions can impact listing performance
📌 Overall Review:
The Sai Parenterals IPO review suggests a neutral outlook. While the company operates in a promising sector, the lack of strong GMP and excitement in the grey market indicates that investors should approach with caution.
🤔 Should You Apply for Sai Parenterals IPO?
Here’s a quick decision guide:
- For Listing Gains: ❌ Not very attractive due to zero GMP
- For Long-Term Investment: ✅ Consider if fundamentals align with your goals
- Risk Appetite: Moderate
👉 Investors should analyze company fundamentals, financials, and market trends before applying.
📌 Conclusion
The Sai Parenterals IPO 2026 presents a mixed opportunity. While the pharma sector outlook is positive, current GMP trends and market sentiment suggest a cautious approach. Investors should focus on long-term potential rather than short-term listing gains.
⚠️ Disclaimer
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. This is only for informational purposes.
Angel One Ltd. is just acting as the distributor of the IPO. Investors are requested to do their due diligence before investing in any IPO. Investor grievance redressal mechanism of exchange would not be available for applying in IPO
📍 Registration Details
Angel One Limited (formerly known as Angel Broking Limited), Registered Office: 601, 6th Floor, Ackruti Star, Central Road, MIDC, Andheri East, Mumbai – 400093.
Tel: 080-47480048
CIN: L67120MH1996PLC101709
SEBI Regn. No.: INZ000161534
Compliance Officer: Mr. Bineet Jha
Tel: (022) 39413940
Email: compliance@angelbroking.com
📞 Contact 4R Investments
📍 3-1-309/310, Tara Kaushalya Nivas, Nimboliadda, Kachiguda, Hyderabad – 500027
📞 6300169336
📧 contact@4rinvestments.in
🌐 https://4rinvestments.in/